Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)

April 2018

Admelog (AD-mah-log) will compete with Humalog as a new BRAND of insulin lispro.

This is similar to the situation with Basaglar and Lantus.

Admelog is not a generic...and isn't technically a biosimilar in the U.S. Instead, FDA calls Admelog and Basaglar "follow-on" brands...they use safety and efficacy data from the original brands for faster approval.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Vaccines Answer Questions About the New Shingles Vaccine Shingrix
Diabetes Don't Think of A1C Goals as "One-Size-Fits-All"
Insulin Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)
Infectious Diseases Expect to See More Oral Vancomycin for C. diff Diarrhea
Fentanyl Patches Follow Safeguards When Dispensing Fentanyl Patches
Cardiology Manage New Warnings About Clarithromycin and Cardiovascular Risk
Aspirin Be Prepared With the Latest Answers About Aspirin
Rheumatoid Arthritis Expect to See Subcutaneous Methotrexate for Rheumatoid Arthritis
Asthma Close the Gap in Asthma Care in Kids
Men's Health Consider if Meds or Supplements May Be Contributing to Male Infertility
Cannabinoids Know How the Rx Cannabinoids Compare

Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents